Search Results - Xiaojiaoyang Li

Advances in the study of emodin: an update on pharmacological properties and mechanistic basis by Qi Zheng, Shuo Li, Xiaojiaoyang Li, Runping Liu

Connect to this object online.

Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases by Jianzhi Wu, Guangrui Huang, Yajing Li, Xiaojiaoyang Li

Connect to this object online.

A new perspective on liver diseases: Focusing on the mitochondria-associated endoplasmic reticulum membranes by Mengyu Guo, Runping Liu, Fukun Zhang, Jiaorong Qu, Yun Yang, Xiaojiaoyang Li

Connect to this object online.

Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead by Runping Liu, Yajing Li, Qi Zheng, Mingning Ding, Huiping Zhou, Xiaojiaoyang Li

Connect to this object online.

Saikosaponins induced hepatotoxicity in mice via lipid metabolism dysregulation and oxidative stress: a proteomic study by Xiaoyu Li, Xiaojiaoyang Li, Junxian Lu, Youyi Huang, Lili Lv, Yongfu Luan, Runping Liu, Rong Sun

Connect to this object online.

Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice by Xiaoyong Xue, Le Wang, Ruiyu Wu, Yufei Li, Runping Liu, Zhi Ma, Kexin Jia, Yinhao Zhang, Xiaojiaoyang Li

Connect to this object online.

Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis by Xiaoyong Xue, Jianzhi Wu, Mingning Ding, Feng Gao, Fei Zhou, Bing Xu, Mingjun Lu, Jun Li, Xiaojiaoyang Li

Connect to this object online.

Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses by Shuni Duan, Xin Li, Junsong Han, Yang Yang, Ranyi Luo, Yajie Cai, Xiaojiaoyang Li, Qi Zheng, Jincheng Guo, Runping Liu

Connect to this object online.

Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease by Xiaojiaoyang Li, Junde Ge, Yajing Li, Yajie Cai, Qi Zheng, Nana Huang, Yiqing Gu, Qi Han, Yunqian Li, Rong Sun, Runping Liu

Connect to this object online.

SRT1720 Alleviates ANIT-Induced Cholestasis in a Mouse Model by Linxi Yu, Xiaoxin Liu, Zihang Yuan, Xiaojiaoyang Li, Hang Yang, Ziqiao Yuan, Lixin Sun, Luyong Zhang, Luyong Zhang, Luyong Zhang, Zhengzhou Jiang, Zhengzhou Jiang

Connect to this object online.

Ferulic Acid Ameliorates Hepatic Inflammation and Fibrotic Liver Injury by Inhibiting PTP1B Activity and Subsequent Promoting AMPK Phosphorylation by Jianzhi Wu, Xiaoyong Xue, Guifang Fan, Yiqing Gu, Fei Zhou, Qi Zheng, Runping Liu, Yajing Li, Boning Ma, Shuo Li, Guangrui Huang, Lin Ma, Xiaojiaoyang Li

Connect to this object online.

Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways by Fei Zhou, Mingning Ding, Yiqing Gu, Guifang Fan, Chuanyang Liu, Yijie Li, Rong Sun, Rong Sun, Jianzhi Wu, Jianchao Li, Jianchao Li, Xiaoyong Xue, Hongjuan Li, Xiaojiaoyang Li

Connect to this object online.

An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimenta... by Shan Lu, Ziqi Meng, Yingying Tan, Chao Wu, Zhihong Huang, Jiaqi Huang, Changgeng Fu, Antony Stalin, Siyu Guo, Xinkui Liu, Leiming You, Xiaojiaoyang Li, Jingyuan Zhang, Wei Zhou, Xiaomeng Zhang, Miaomiao Wang, Jiarui Wu

Connect to this object online.